Salvatore Calabrese
2020
In 2020, Salvatore Calabrese earned a total compensation of $319.4K as Chief Financial Officer at Gain Therapeutics.
Compensation breakdown
| Bonus | $21,095 |
|---|---|
| Non-Equity Incentive Plan | $25,086 |
| Option Awards | $202,253 |
| Salary | $41,810 |
| Other | $29,116 |
| Total | $319,360 |
Calabrese received $202.3K in option awards, accounting for 63% of the total pay in 2020.
Calabrese also received $21.1K in bonus, $25.1K in non-equity incentive plan, $41.8K in salary and $29.1K in other compensation.
Rankings
In 2020, Salvatore Calabrese's compensation ranked 12,025th out of 13,090 executives tracked by ExecPay. In other words, Calabrese earned more than 8.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,025 out of 13,090 | 8th |
Division Manufacturing | 5,143 out of 5,618 | 9th |
Major group Chemicals And Allied Products | 2,095 out of 2,251 | 7th |
Industry group Drugs | 1,825 out of 1,951 | 7th |
Industry Pharmaceutical Preparations | 1,355 out of 1,456 | 7th |
Source: SEC filing on May 13, 2022.
Calabrese's colleagues
We found one more compensation record of an executive who worked with Salvatore Calabrese at Gain Therapeutics in 2020.
2020
Eric Richman
Gain Therapeutics